|
9661 |
Upadacitinib bei atopischer Dermatitis
Enthalten in Hautnah Bd. 19, 17.11.2020, Nr. 4, date:11.2020: 138-139
|
|
|
|
9662 |
Upadacitinib bei Patienten mit rheumatoider Arthritis
Enthalten in Rheuma plus Bd. 18, 26.7.2019, Nr. 6, date:11.2019: 222-226
|
|
|
|
9663 |
Upadacitinib bei Patienten mit rheumatoider Arthritis
Enthalten in Der Internist Bd. 60, 17.4.2019, Nr. 5, date:5.2019: 549-552
|
|
|
|
9664 |
Update Gynäkologie
Enthalten in Der Gynäkologe Bd. 52, 10.5.2019, Nr. 5, date:5.2019: 322-323
|
|
|
|
9665 |
Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial
Enthalten in Trials Bd. 20, 4.12.2019, Nr. 1, date:12.2019: 1-9
|
|
|
|
9666 |
Update zur idiopathischen Lungenfibrose
Enthalten in Pneumo news Bd. 10, 10.11.2018, Nr. 7, date:11.2018: 53
|
|
|
|
9667 |
Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial
Enthalten in Trials Bd. 25, 22.7.2024, Nr. 1, date:12.2024: 1-13
|
|
|
|
9668 |
Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study
Enthalten in Trials Bd. 20, 16.4.2019, Nr. 1, date:12.2019: 1-10
|
|
|
|
9669 |
Urothelkarzinom: Antikörper verlängert krankheitsfreies Überleben nach Komplettresektion
Enthalten in Im Focus Onkologie Bd. 24, 8.12.2021, Nr. 6, date:12.2021: 25
|
|
|
|
9670 |
Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root, in the treatment of symptoms of overactive bladder and urinary incontinence: a phase 2, randomised, double-blind placebo controlled trial
Enthalten in BMC complementary and alternative medicine Bd. 18, 31.1.2018, Nr. 1, date:12.2018: 1-11
|
|
Administration
